Cystic Fibrosis Weekly Update

Contents:

Orkambi Benefits CF Patients Across Levels of Lung Health, Study Finds

Jul 08, 2020 07:00 am | Patricia Inacio, PhD

Orkambi (ivacaftor/lumacaftor) can significantly reduce the number of days people with cystic fibrosis (CF) require intravenous antibiotics for flares and helps with weight gain — independently of a patient’s level of lung function at the start of treatment, a real-world study reported. While the greatest lung improvements were seen in patients with suboptimal lung function at treatment […]
The post Orkambi Benefits CF Patients Across Levels of Lung Health, Study Finds appeared first on Cystic Fibrosis News Today.

I Don’t Want to Die Because You Don’t Like Masks

Jul 07, 2020 03:00 pm | Bailey Vincent

walk, pre-existing condition, perspective, slowing down

Wear a mask for me. The more I see friends post anti-mask passions as if they were a political statement, the more I wonder if they’ve ever met me. It’s not about me, right? Well, in this case, it is. The inability to wear a mask to protect someone like me (so that I can […]
The post I Don’t Want to Die Because You Don’t Like Masks appeared first on Cystic Fibrosis News Today.

Common P. aeruginosa Mutations May Lead to Biofilm Growth, Bacterial Persistence, Study Says

Jul 07, 2020 07:00 am | Marta Figueiredo

The common mutations that cause Pseudomonas aeruginosa to lose their ability to move are associated with a higher production of two complex sugar molecules implicated in the formation of biofilms — slimy layers of microorganisms that stick to wet surfaces and protect them from antibiotics and the host’s immune response, a study has found. These mutations […]
The post Common P. aeruginosa Mutations May Lead to Biofilm Growth, Bacterial Persistence, Study Says appeared first on Cystic Fibrosis News Today.